Inflammatory and autoimmune predictive markers of response to anti-PD-1/PD-L1 therapy in NSCLC and melanoma

Immune checkpoint inhibitors (ICI) are a standard in cancer therapy, but few patients respond to the treatment. The aim of the present study was the determination of immunological markers for monitoring response to ICI. The present study included 74 patients receiving ICI in subsequent [group 1; non...

Descripción completa

Detalles Bibliográficos
Autores principales: Musaelyan, Aram A., Lapin, Sergey V., Urtenova, Margarita A., Odintsova, Svetlana V., Chistyakov, Ivan V., Ulitin, Andrey M., Akopov, Andrey L., Orlov, Sergey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366266/
https://www.ncbi.nlm.nih.gov/pubmed/35978940
http://dx.doi.org/10.3892/etm.2022.11495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366266/
https://www.ncbi.nlm.nih.gov/pubmed/35978940
http://dx.doi.org/10.3892/etm.2022.11495

Ejemplares similares